How pain management clinics evaluate a biologics distributor
A pain management or physical medicine practice typically layers vendor review on top of its existing compliance process: confirming the distributor restricts sales to licensed professionals, confirming pricing is reserved for verified accounts rather than published, and confirming registration and licensure documentation is available for direct review.
Because exosome products are not approved by the FDA and are generally regulated as biologic drugs under section 351 of the Public Health Service Act, clinics in this specialty often ask for that regulatory framing up front rather than discovering it after a purchase decision.
Austin
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
204- Pain Medicine
- 89
- Physical Medicine & Rehabilitation
- 115
Documentation to request and keep on file
The same core records apply whether a clinic is stocking a Wharton's jelly format or an exosome format.
- Certificate of analysis for the specific lot
- Donor eligibility summary
- Lot release record showing quarantine and release criteria were met
- Characterization data for exosome products, on request
Shipping and receiving in Texas
Cryopreserved products ship overnight on dry ice in validated containers and are kept at -80 degrees C until use; lyophilized formats ship shelf-stable per the insert supplied with the lot. An Austin clinic's intake process should match the lot identifier on the shipment to the paperwork before the product is logged into inventory at the patient-record level.
Verify your own regulatory posture
Whether a given Wharton's jelly or exosome product and its intended use fit a clinic's regulatory framework, and any Texas-specific scope-of-practice questions, are matters for the clinic's own counsel and, where relevant, the Texas Medical Board, not a distributor. Precision Biologics supports account verification, documentation on request, and physician-level calls about that documentation.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Is there an FDA-approved exosome product our clinic can purchase?+
No. The FDA has stated there are no FDA-approved exosome products, and they are generally regulated as biologic drugs. Any clinical use decision rests with the treating physician and your own regulatory counsel.
How does account verification work for an Austin pain management practice?+
Accounts are verified through the practice's NPI number and limited to licensed professionals; pricing is never published and is shared only with verified accounts.
What should our intake process check when a shipment arrives?+
Match the lot identifier on the shipment to your paperwork and confirm the cold chain held before logging the product into inventory.